Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma.

ABSTRACT:

SUBMITTER: Petrillo A 

PROVIDER: S-EPMC9208873 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature